Workflow
瑞丰高材(300243) - 2023 Q1 - 季度财报
RUIFENG CHEMRUIFENG CHEM(SZ:300243)2023-04-24 16:00

Financial Performance - The company's operating revenue for Q1 2023 was ¥410,808,987.33, a decrease of 18.04% compared to ¥501,228,023.58 in the same period last year[6] - Net profit attributable to shareholders was ¥17,683,765.50, down 43.67% from ¥31,394,431.21 year-on-year[6] - Basic earnings per share decreased by 42.86% to ¥0.08 from ¥0.14 in the same period last year[6] - Total operating revenue for Q1 2023 was CNY 410,808,987.33, a decrease of 18.0% compared to CNY 501,228,023.58 in Q1 2022[20] - Net profit for Q1 2023 was CNY 17,683,765.50, representing a decline of 43.8% from CNY 31,394,431.21 in Q1 2022[21] - Basic earnings per share for Q1 2023 were CNY 0.08, down from CNY 0.14 in Q1 2022[22] Cash Flow - The net cash flow from operating activities improved to -¥41,475,544.99, a 54.40% increase compared to -¥90,964,610.07 in the previous year[6] - Cash flow from operating activities for Q1 2023 showed a net outflow of CNY 41,475,544.99, an improvement from a net outflow of CNY 90,964,610.07 in Q1 2022[23] - The net cash flow from financing activities significantly increased by 1679.19% to ¥66,816,552.06, up from ¥3,755,450.89 in the same period last year[10] - Cash inflow from financing activities totaled 139,300,000.00, an increase from 117,500,000.00 year-over-year[25] - The net cash flow from financing activities was 66,816,552.06, significantly higher than 3,755,450.89 in the same period last year[25] - The net cash flow from investment activities was -28,690,044.52, compared to -5,212,669.71 in the previous year[25] Assets and Liabilities - Total assets increased by 3.43% to ¥2,008,137,515.92 from ¥1,941,503,163.88 at the end of the previous year[6] - The company reported a significant increase in non-current liabilities due within one year, rising by 67.25% to ¥115,400,000.00 from ¥69,000,000.00[10] - The total liabilities as of Q1 2023 were CNY 1,054,134,571.14, an increase from CNY 1,006,009,276.05 in Q1 2022[18] - The total equity attributable to shareholders of the parent company was CNY 954,002,944.78, up from CNY 935,493,887.83 in the previous year[18] Shareholder Information - Total number of common shareholders at the end of the reporting period is 16,930[12] - The largest shareholder, Zhou Shibin, holds 22.28% of shares, totaling 51,752,197 shares[12] Research and Development - Research and development expenses rose by 35.46% to ¥1,174,232.85 compared to ¥866,834.70 in the previous year[10] - Research and development expenses increased to CNY 1,174,232.85 in Q1 2023, up from CNY 866,834.70 in Q1 2022, indicating a focus on innovation[20] Other Financial Metrics - The company's weighted average return on equity decreased to 1.84% from 3.45% year-on-year[6] - The company received government subsidies amounting to ¥527,673.57 during the reporting period, which is a decrease of 57.84% compared to the previous year[10] - The company reported a decrease in other income to CNY 527,673.57 in Q1 2023 from CNY 1,251,557.70 in Q1 2022, indicating potential challenges in ancillary revenue streams[21] Current Assets and Liabilities - The company’s total current assets amount to 985,233,433.10 CNY, an increase from 947,485,102.13 CNY at the beginning of the year[17] - Total current liabilities increased to 693,928,165.57 CNY from 622,779,315.62 CNY[17] - Cash and cash equivalents decreased to 169,897,990.13 CNY from 186,050,514.28 CNY[15] - Accounts receivable increased to 326,802,688.34 CNY from 292,807,449.02 CNY[15] - Inventory increased to 254,270,511.48 CNY from 203,099,658.77 CNY[15] - The total non-current assets amount to 1,022,904,082.82 CNY, an increase from 994,018,061.75 CNY[17] Audit Information - The company did not undergo an audit for the first quarter report[26]